应用技术来简化1型糖尿病运动策略
Bruce A Perkins1,2, Lauren V Turner3, Michael C Riddell3
1Leadership Sinai Centre for Diabetes, Sinai Health, Toronto, ON, Canada. Bruce.Perkins@sinaihealth.ca.
Diabetologia
|August 15, 2024
概括
在运动期间控制葡萄糖水平对于1型糖尿病 (T1D) 患者至关重要. 本综述为临床医生提供了实用策略和六个步骤,以帮助T1D患者安全有效地进行炼.
科学领域:
- 内分泌学和新陈代谢学
- 运动生理学 运动生理学
- 糖尿病 技术 技术
背景情况:
- 对于1型糖尿病 (T1D) 患者来说,在体育活动期间控制血糖对健康结果和生活质量都产生重大影响,这对1型糖尿病 (T1D) 患者来说是一个重大挑战.
- 技术进步,如持续血糖监测 (CGM),开放循环胰岛素治疗和混合闭环 (HCL) 系统,为T1D的运动相关血糖管理提供了潜在的解决方案.
研究的目的:
- 将当前的研究成果和专家经验转化为简化,以患者为中心的策略,以控制T1D患者在运动期间的葡萄糖水平.
- 为临床医生提供一个实际的六步框架,有效地向T1D患者传达运动管理指南.
主要方法:
- 一篇综合出版文献,临床经验和三位T1D专家的个人见解的综述.
- 制定六步策略,重点了解胰岛素的药理动力学,运动诱导的葡萄糖利用和技术系统能力.
- 建议的策略包括估计运动所需的碳水化合物 ("ExCarbs") 和建议预先减少基础胰岛素或HCL运动模式用于计划的运动.
主要成果:
- 建议采用简化的六步方法,指导临床医生向T1D患者传达运动管理策略.
- 关键建议包括估计自发运动的额外碳水化合物摄入量 ("ExCarbs"),并实施预先的基础胰岛素调整或计划运动的HCL运动模式.
- 对于有氧和无氧运动类型,讨论了具体的修改.
结论:
- 像HCL系统这样的现有技术需要先发制人的基础胰岛素降低和"ExCarbs"的消费,这代表了当前的局限性.
- 这些策略对于使用当前的T1D技术来安全进行管理至关重要,未来的创新可能会减轻这些负担.
- 这些简化策略的有效沟通对于改善T1D患者的生活质量和炼结果至关重要.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
246
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
246
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:16Insulin: Dosing Regimen and Adverse Effects
161
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
161
01:36Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183